INCIDENCE AND ECONOMIC BURDEN OF HOSPITAL READMISSIONS AMONG PATIENTS UNDERGOING MAJOR PANCREATIC RESECTION
Author(s)
Guilfoyle J1, Bhutiani N2, Johnston S1, Dwarakanathan H3, Patkar A4, Martin II RC2
1Johnson & Johnson, New Brunswick, NJ, USA, 2University of Louisville, Louisville, KY, USA, 3Mu Sigma, Bangalore, India, 4Johnson & Johnson, Somerville, NJ, USA
Presentation Documents
OBJECTIVES: Hospital readmissions after pancreatic resection have been identified as an area of clinical and economic concern. However, most prior studies have focused only on 30-day readmissions and are based on data prior to 2015. This study uses more contemporary data to describe the incidence, indications, and economic burden of 30, 60, and 90-day all-cause readmissions among patients undergoing distal pancreatectomy (DP), pancreaticoduodenectomy (PD), or total pancreatectomy (TP). METHODS: Data on patients aged ≥18 years undergoing pancreatic resection between October 2015 and March 2019 (first=index admission) were extracted from the Premier Healthcare Database. The primary study outcomes were 30, 60, and 90-day all-cause readmission. The admission type (elective vs. non-elective), primary diagnosis, primary procedure, length of stay (LOS), and total hospital costs of readmissions during these time periods was also collected. All analyses were descriptive in nature. RESULTS: A total of 3,775 patients underwent DP, 5,510 underwent PD, and 254 underwent TP. Overall, 255 patients (2.5%) died during the index admission. Among those surviving, the readmission rate at 30, 60, and 90 days was 22.4%, 25.8%, and 28.0%. The proportion of readmissions that were non-elective was consistent across time periods, ranging from 91.1%-91.4%. The most common primary diagnoses for readmissions in all three time periods were related to infection/sepsis/peritoneal abscess (35.3%-38.0%). In congruence, the most common primary procedures were for drainage (36.0%-39.0%). The mean (standard deviation, median) LOS and cost of the index admission were 10.8 (10.5, 8.0) days and $38,299 ($37,904, $29,162). In comparison, these values were 7.2 (8.4, 5.0) days and $16,719 ($27,389, $9,407) per readmission over the 90-day follow-up and very similar in magnitude at 30 and 60 days. CONCLUSIONS: All-cause readmissions are common after major pancreatic resection and continue to accrue beyond the 30-day post-discharge timepoint. Such readmissions tend to be non-elective and are associated with a significant economic burden.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA
Value in Health, Volume 23, Issue 5, S1 (May 2020)
Code
PSU13
Topic
Economic Evaluation, Epidemiology & Public Health
Topic Subcategory
Public Health
Disease
Surgery